D-1MT
Term · Oncology and biomedicine · MLC-T-ONC-002259
A substance being studied in the treatment of melanoma and many other types of cancer. D-1MT blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving D-1MT to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called 1-methyl-d-tryptophan.
| Identifier | MLC-T-ONC-002259 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | 1-methyl-d-tryptophan |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002259",
"term": "D-1MT",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of melanoma and many other types of cancer. D-1MT blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving D-1MT to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called 1-methyl-d-tryptophan.",
"expansions": [
"1-methyl-d-tryptophan"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/d-1mt/"
}
Record 5,639 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.